adjuvants to enhance the efficacy of immune checkpoint inhibitors and other potent cancer therapies, and advancing new approaches to immunization against emerging infectious diseases. Revium Rx's advanced encapsulated therapeutics are built on three core technologies: clinically proven nanoparticles, advanced drug-loading and release systems, and specialized lipid-based microcarriers. By addressing the critical need for safer and more effective treatments, Revium Rx leverages these innovative systems to maximize safety and efficacy, expand therapeutic potential, and confront some of the most challenging diseases with transformative outcomes.